Clinical trials: Persistent Babesiosis
Persistent Babesiosis
Expanded Use in Persistent (B. Microti) Babesiosis
The purpose of this expanded access protocol is to offer a potentially effective treatment (tafenoquine) to patients with persistent babesiosis, who have not responded to standard of care treatments, and who are immunocompromised…
- Trial name
- NCT06478641
- Testing
- Tafenoquine
- Sponsor
- 60 Degrees Pharmaceuticals LLC